More articles from Preclinical Probes for Oncology

You have access
Development of 43Sc/47Sc-PSMA-617 as Theranostics for Prostate Cancer: Preliminary Cellular and Animal Studies
Jason Meier, Mohammed Bhuiyan, Hannah Zhang, Hsiu-Ming Tsai, Lucas Berens, Lara Leoni, Megan Mendez, Phillip Selman, Pavithra Kankanamalage, Thomas Brossard, Brittany Broder, Amy Renne, Matt Gott, John Greene, Jerry Nolen, Richard Freifelder, Walter Stadler, Ralph Weichselbaum, Chien-Min Kao, David Rotsch, Russell Szmulewitz and Chin-Tu Chen

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2895;
You have access
Characterization of Radiolabeled Peptides for PET Imaging of CD206 Positive Macrophages in Cancer
Candace Parker, Ahmad Bin Salam, Jesse Jaynes, Addison Hunt, Clayton Yates and Suzanne Lapi

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2871;
You have access
Establishment of efficacy of DOTA-based pretargeted radioimmunotherapy with a bivalent radiohapten for enhanced therapeutic indices
Brett Vaughn, Darren Veach, Daniela Burnes Vargas, Shin Seo, Blesida Punzalan, Pat Zanzonico, Hong Xu, Hong-fen Guo, Guangbin Yang, Ouathek Ouerfelli, Nai-Kong Cheung, Steven Larson and Sarah Cheal

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2881;
You have access
TAM Targeted Imaging Agents Binding CD206 and Selective Blocking of Off Target Liver Localization
Jennifer Bartels, Solana Fernandez, Jeffrey Arnold, Grace O'Malley, David Ralph and Suzanne Lapi

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2862;
You have access
A Novel approach for ovarian cancer detection
Sushil Tripathi and Mathew Thakur

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2889;
You have access
Formulation and preclinical analysis of 68Ga/177Lu/225Ac labeled αvβ3-integrin targeting peptidomimetic (IAC) for PET Imaging and targeted radionuclide therapy
Somit Pandey, JAYA SHUKLA, Gurvinder Gill, Rakhee Vatsa, Imraan Rather, Vijayta Chadha and STANLEY SATZ

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2879;
You have access
Development of [111In]In-CHX-A”-DTPA-αCD68 as a SPECT Agent for Non-Invasive Tracking of Macrophages In Vivo
Erika Belitzky, Alessandra Cavaliere, Samantha Katz, Michael Liu, Khashayar Rajabimoghadam and Bernadette Marquez-Nostra

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2869;
You have access
Simultaneous molecular imaging and biodistribution of two radiolabeled domain-specific anti-HER2 antibody drug conjugates in HER2-positive xenografts
Jessica Pougoue Ketchemen, Hanan Babeker, Anjong Tikum, Anand Nambisan, Fabrice Ngoh Njotu, Musharraf Khan and Humphrey Fonge

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2866;
You have access
Visualizing cytokeratin-14 levels in basal-like breast cancer via immunoSPECT imaging
Hao Ji, Xiao Zhang, Yongkang Gai and Xiaoli Lan

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2873;
You have access
Radiosynthesis and preclinical evaluation of Al[18F]F-NOTA-C-(D-VAP) as a potential tumor PET probe targeting GRP78
Shun Huang, Jianwen Huang, Yanjiang Han, Penghui Sun and Guanghua Tang

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2868;

Main menu

User menu

Search

More articles from Preclinical Probes for Oncology

Pages